Understanding infliximab in Crohn's disease: the long-term outcomes

Dig Dis Sci. 2013 Mar;58(3):604-7. doi: 10.1007/s10620-012-2504-x.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Humans
  • Paclitaxel / pharmacology*
  • Stents*

Substances

  • Antineoplastic Agents, Phytogenic
  • Paclitaxel